Indofarma Tbk (INAF) — Capital Reinvestment Ratio
Indofarma Tbk (INAF) has a Capital Reinvestment Ratio of 0.00x as of December 2024, meaning it reinvests 0% of its operating cash flow (Rp34.01 Billion) in capital expenditures (Rp6.94 Million). Check INAF tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Indofarma Tbk Capital Reinvestment Ratio (2000–2021)
This chart tracks Indofarma Tbk's Capital Reinvestment Ratio across 14 annual periods. For the full cash flow conversion analysis, see INAF cash flow metrics.
Annual Capital Reinvestment Ratio for Indofarma Tbk (2000–2021)
Year-by-year Capital Reinvestment Ratio for Indofarma Tbk from 2000 to 2021. See INAF free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (IDR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.23x | Rp92.90 Billion | Rp21.40 Billion | ▼ -22.2% |
| 2020 | 0.30x | Rp46.55 Billion | Rp13.78 Billion | ▲ +137.0% |
| 2019 | 0.12x | Rp20.79 Billion | Rp2.60 Billion | ▼ -80.6% |
| 2017 | 0.64x | Rp147.18 Billion | Rp94.87 Billion | ▲ +277.1% |
| 2015 | 0.17x | Rp134.28 Billion | Rp22.95 Billion | ▼ -54.6% |
| 2014 | 0.38x | Rp148.73 Billion | Rp56.05 Billion | ▲ +140.7% |
| 2011 | 0.16x | Rp29.40 Billion | Rp4.60 Billion | ▼ -33.3% |
| 2010 | 0.23x | Rp23.71 Billion | Rp5.57 Billion | ▼ -56.0% |
| 2009 | 0.53x | Rp40.56 Billion | Rp21.65 Billion | ▲ +1507.3% |
| 2007 | 0.03x | Rp83.42 Billion | Rp2.77 Billion | ▲ +44.4% |
| 2006 | 0.02x | Rp73.15 Billion | Rp1.68 Billion | ▲ +470.4% |
| 2004 | 0.00x | Rp159.25 Billion | Rp642.02 Million | ▼ -98.0% |
| 2003 | 0.21x | Rp40.70 Billion | Rp8.36 Billion | ▼ -89.2% |
| 2000 | 1.90x | Rp27.05 Billion | Rp51.43 Billion | — |